31st May 2016 09:27
LONDON (Alliance News) - Antibody specialist Bioventix PLC on Tuesday said it has signed a collaboration agreement with Norway-based Alzheimer's disease diagnostics firm Pre Diagnostics AS.
Under the deal, Bioventix will develop and provide antibodies for Pre Diagnostics' new IVD test for dementia.
No financial details were disclosed.
"We are delighted to be involved with Pre Diagnostics and their beta amyloid project. We are very impressed by the Oslo-based group and their research partners, their thorough approach to basic science, and their ability to apply this to clinical research," said Bioventix Chief Executive Peter Harrison.
Shares in Bioventix were up 0.5% to 1,037.50 pence Tuesday.
By Sam Unsted; [email protected]; @SamUAtAlliance
Copyright 2016 Alliance News Limited. All Rights Reserved.
Related Shares:
Bioventix